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The relationship between insulin resistance and carotid artery
intima-media thickness in obese and morbidly obese women
Gülçin Cengiz ECEMİŞ1, Hakkı KAHRAMAN1, Mehmet Selim NURAL2, Halil Serdar ASLAN2,
Ayşegül ATMACA1

Aim: To compare insulin resistance and carotid intima-media thickness (IMT) between obese, morbidly obese, and
healthy women and demonstrate whether there is a relation between these parameters, focusing mainly on morbidly
obese women.
Materials and methods: Twenty-five morbidly obese women (body mass index (BMI) ≥ 40 kg/m²), 25 obese women
(BMI 30–39.9 kg/m2), and 25 age-matched healthy women (BMI 18.5–24.9 kg/m2) were recruited for the study. None
of the subjects had diabetes mellitus. BMI, waist-to-hip ratio, lipid profiles, fasting glucose and insulin levels, insulin
resistance (by HOMA), and IMT (common carotid, internal carotid, and bifurcation measurements) were compared
among the 3 groups and between obese and morbidly obese women.
Results: IMT, HOMA, triglyceride, HDL cholesterol, fasting glucose, and insulin levels were higher in obese and
morbidly obese women. In the morbidly obese women, internal carotid IMT was positively correlated with fasting
insulin. In the combined group of obese and morbidly obese women, internal carotid IMT was positively correlated with
both fasting insulin and HOMA.
Conclusion: Increased carotid IMT is an early sign of atherosclerosis in nondiabetic obese women as well and is related
to both hyperinsulinemia and insulin resistance.
Key words: Obesity, morbid obesity, carotid artery intima media thickness, insulin resistance, hyperinsulinemia

Introduction
Android obesity is the deposition of fat in the abdominal
region, around the visceral organs. It leads to insulin
resistance, which is associated with increased risk of
diabetes mellitus (DM), dyslipidemia, hypertension,
and atherosclerosis, resulting in increased morbidity
and mortality rates (1). Insulin sensitivity is decreased
by 30% to 40% in people who are 35% more than
their ideal weight (2). Hyperinsulinemia per se is also
associated with most of the risk factors of atherosclerosis
and is an independent risk factor for coronary artery
disease (3).

Measurement of carotid artery intima-media
thickness (IMT) with high resolution B-mode
ultrasonography is a valuable method for monitoring
atherosclerotic changes (4). Every 0.1 mm increase in
carotid artery IMT is associated with an 11% increase
in the risk of acute myocardial infarction (5).
Many studies have been conducted to show the
relation between insulin resistance and coronary
artery disease. However, there are methodological
differences among these studies regarding the patient
characteristics, methods used to determine insulin
resistance, drugs used, and period of follow-up.
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The results of these studies also differ. Some studies
demonstrate a relation between hyperinsulinemia or
insulin resistance and carotid IMT, while others do
not. To date, no study has been conducted to show
whether there are any differences in insulin resistance
and carotid IMT between obese and morbidly obese
patients. The aim of this study was to compare
insulin resistance, lipid parameters, blood pressure,
and carotid IMT among obese, morbidly obese, and
healthy control groups and to demonstrate whether
there is a relation between these parameters, focusing
mainly on morbidly obese patients.
Materials and methods
Twenty-five morbidly obese women (body mass index
(BMI) ≥ 40 kg/m2), 25 obese women (BMI 30.0–39.9
kg/m2), and 25 healthy age-matched women as the
control group (BMI 18.5–24.9 kg/m2) were enrolled
in the study. Subjects with DM, other endocrine
disorders, congestive heart failure, chronic renal and
hepatic failure, acute or chronic infection, and cancer
were excluded from the study. Subjects who were less
than 18 years old, who used antihypertensive drugs,
or whose systolic and diastolic blood pressures were
≥210 mmHg and ≥120 mmHg, respectively, were also
excluded. Informed consent was obtained from all
subjects and the study was conducted in accordance
with principals of the Declaration of Helsinki.
Age (years), height (m), weight (kg), waist and
hip circumferences (cm), and systolic and diastolic
blood pressures (mmHg) were noted for all subjects.
Waist-to-hip ratios and BMIs were calculated. Blood
samples were drawn after an overnight fast of 12 h
between 08.00 and 09.00 hours for fasting plasma
glucose, insulin, triglycerides, total cholesterol, lowdensity lipoprotein (LDL) cholesterol, and highdensity lipoprotein (HDL) cholesterol. A 75-g oral
glucose tolerance test was performed following a
diet with ≥150 g/day of carbohydrates for 3 days to
exclude DM. After an overnight fast, subjects were
asked to drink 75 g of glucose in 200 mL water in 5
min. Blood was drawn for glucose and insulin before
and 2 h after glucose loading. Insulin resistance was
determined according to the Homeostasis Model
Assessment (HOMA) formula (6):
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[Fasting insulin (mIU/L) × fasting glucose (mg/
dL) × 0.05551] / 22.5.
Carotid artery IMT of all subjects was measured
with high resolution B-mode ultrasonography by the
same radiologist. Ultrasonography was performed
with real-time equipment (PowerVision 7000 SSA380A; Toshiba Corporation, Tokyo, Japan) and a 10MHz linear probe. The 6 sites that were measured
were the right and left common carotid artery (CCA),
right and left internal carotid artery (ICA), and right
and left bifurcation (BCA). The measurements were
carried out in regions without plaque formation. The
mean of the right and left measurements was used for
the analyses.
Statistical analyses were carried out with SPSS 13.0.
Values were expressed as mean ± standard deviation.
P < 0.05 was considered statistically significant.
Normality was tested by the Kolmogorov–Smirnov
test. Normally distributed data were analyzed by
using one-way ANOVA and differences between
groups were analyzed by Tukey multiple comparisons.
Nonnormally distributed data were analyzed by the
Kruskal–Wallis test and differences between groups
were analyzed by the Mann–Whitney U test. The
Pearson correlation test was used for correlation
analysis.
Results
Clinical characteristics and laboratory parameters
of the groups are shown in Table 1. There was a
statistically significant difference in the IMT of the
CCA, ICA, and BCA, and the triglyceride, HDL
cholesterol, fasting plasma glucose, and insulin levels
among the 3 groups (Table 1, Figures 1a–1c). There
was also a statistically significant difference in CCA,
ICA, and BCA IMTs when obese and morbidly obese
groups were compared separately (Table 2). Waistto-hip ratio, systolic and diastolic blood pressures,
triglyceride, total cholesterol, LDL and HDL
cholesterol levels, fasting plasma glucose and insulin
levels, and HOMA indexes were not statistically
significant between the 2 groups (Table 2).
There was a statistically significant difference in
HOMA indexes among the 3 groups (P = 0.0001)
(Table 1). However, the difference was not statistically
significant when obese and morbidly obese groups
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Table 1. Clinical characteristics and laboratory parameters of the study groups.
Morbidly obese

Obese

Control

P-value

Age (years)

44.7 ± 9.8

44.7 ± 12.5

41.8 ± 112

NS

BMI (kg/m2)

47.9 ± 5.6

34.9 ± 2.5

22.3 ± 1.9

0.0001

WHR

0.86 ± 0.06

0.86 ± 0.05

0.80 ± 0.00

0.0001

SBP (mmHg)

139.0 ± 20.7

134.0 ± 20.0

107.4 ± 12.2

0.0001

DBP (mmHg)

89.4 ± 13.0

86.0 ± 12.9

70.2 ± 11.4

0.0001

TG (mg/dL)

162.1 ± 79.3

137.9 ± 67.2

86.1 ± 45.5

0.0001

TC (mg/dL)

203.7 ± 44.6

205.3 ± 45.6

178.6 ± 47.7

NS

LDL-C (mg/dL)

125.3 ± 38.3

116.0 ± 41.2

99.7 ± 36.5

NS

HDL-C (mg/dL)

45.3 ± 13.1

54.3 ± 15.6

62.8 ± 16.9

0.001

Fasting glucose (mg/dL)

95.2 ± 12.7

95.9 ± 14.1

79.3 ± 8.7

0.0001

Fasting insulin (mIU/L)

17.2 ± 9.0

11.7 ± 7.0

5.4 ± 4.3

0.0001

HOMA

4.1 ± 2.3

2.8 ± 1.8

1.1 ± 1.0

0.0001

CCA IMT (mm)

0.7 ± 0.2

0.6 ± 0.2

0.4 ± 0.1

0.0001

ICA IMT (mm)

0.6 ± 0.1

0.5 ± 0.1

0.3 ± 0.1

0.0001

BCA IMT (mm)

0.7 ± 0.2

0.6 ± 0.2

0.5 ± 0.1

0.0001

BMI, body mass index; WHR, waist-to-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; TC,
total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; HOMA, homeostasis model
assessment; CCA IMT, intima media thickness of common carotid artery; ICA IMT, intima media thickness of internal carotid artery;
BCA IMT, intima media thickness of common carotid artery bifurcation.
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Figure 1. The mean a) CCA IMT, b) ICA IMT, and c) BCA IMT of the study groups (P = 0.0001 for all).
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Table 2. Clinical characteristics and laboratory parameters of morbidly obese and obese women.
Morbidly obese

Obese

P-value

Age (years)

44.7 ± 9.8

44.7 ± 12.5

NS

BMI (kg/m2)

47.9 ± 5.6

34.9 ± 2.5

0.0001

WHR

0.86 ± 0.06

0,86 ± 0.05

NS

SBP (mmHg)

139.0 ± 20.7

134.0 ± 20.0

NS

DBP (mmHg)

89.4 ± 13.1

86.0 ± 12.9

NS

TG (mg/dL)

162.1 ± 79.4

137.9 ± 67.2

NS

TC (mg/dL)

203.7 ± 44.6

205.3 ± 45.6

NS

LDL-C (mg/dL)

125.3 ± 38.3

116.0 ± 41.2

NS

HDL-C (mg/dL)

45.3 ± 13.1

54.3 ± 15.6

NS

Fasting glucose (mg/dL)

95.2 ± 12.7

95.9 ± 14.1

NS

Fasting insulin (mIU/L)

17.2 ± 9.0

11.7 ± 7.0

NS

HOMA

4.1 ± 2.3

2.8 ± 1.8

NS

CCA IMT (mm)

0.7 ± 0.2

0.6 ± 0.2

0.036

ICA IMT (mm)

0.6 ± 0.1

0.5 ± 0.1

0.028

BCA IMT (mm)

0.7 ± 0.2

0.6 ± 0.1

0.035

BMI, body mass index; WHR, waist-to-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG,
triglyceride; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein
cholesterol; HOMA, homeostasis model assessment; CCA IMT, intima media thickness of common carotid artery; ICA
IMT, intima media thickness of internal carotid artery; BCA IMT, intima media thickness of common carotid artery
bifurcation.

When the morbidly obese and obese groups were
combined (all women with BMI ≥ 30 kg/m2), the ICA
IMT was positively correlated with fasting insulin (r
= 0.35, P = 0.01) and HOMA index (r = 0.30, P =
0.02) (Figures 3a and 3b). In the combined group,
there was also a positive correlation between BMI
and ICA IMT (r = 0.30, P = 0.04) and BMI and CCA
IMT (r = 0.30, P = 0.04) (Figures 4a and 4b).
1124

0.9
0.8
0.7
ICA-IMT (mm)

were compared separately (Table 2). In the morbidly
obese group, there was no correlation between
HOMA index and BMI or between HOMA index
and IMT measurements. The mean ICA IMT was
positively correlated with fasting insulin (r = 0.40,
P = 0.03) (Figure 2). In the morbidly obese group,
a negative correlation between HDL cholesterol and
fasting insulin (r = –0.6, P = 0.004) and between HDL
cholesterol and HOMA index (r = –0.5, P = 0.007)
was also found.
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Figure 2. Correlation between ICA IMT and fasting insulin in
morbidly obese women (r = 0.40, P = 0.03).
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Figure 3. Correlation between a) ICA IMT and fasting insulin (r = 0.35, P = 0.01) and b) ICA IMT and HOMA index (r = 0.30, P =
0.02) in all obese women with BMI ≥ 30 kg/m2.
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Figure 4. Correlation between a) ICA IMT and BMI (r = 0.30, P = 0.04) and b) CCA IMT and BMI (r = 0.30, P = 0.04) in all obese
women with BMI ≥ 30 kg/m2.

Discussion
Obesity is generally related with insulin resistance,
which leads to hypertension, type 2 DM, and
dyslipidemia (7). The gold standard for the evaluation
of insulin resistance is the hyperinsulinemic
euglycemic glucose clamp technique. However, its
use is limited because it is invasive, expensive, timeconsuming, and complex (8). The HOMA index is
calculated with the use of fasting glucose and insulin.

It is better correlated with hepatic than peripheral
insulin sensitivity (9). Sourij et al. compared the
short insulin tolerance test and HOMA in 1171
overweight patients and demonstrated that HOMA
is better correlated with carotid artery IMT and
atherosclerosis than the short insulin tolerance test
(10). Since it is easy to perform, cost-effective, and
noninvasive, the HOMA index was used to evaluate
insulin resistance in this study.
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In this study, there was a positive correlation
between fasting insulin and ICA IMT in morbidly obese
women. However, there was no correlation between
the HOMA index and any of the IMT measurements.
To date, no study has evaluated the carotid artery IMT
and its relation with insulin levels and insulin resistance
in morbidly obese patients only. When obese and
morbidly obese women were combined as one group,
both fasting insulin levels and the HOMA index were
positively correlated with ICA IMT. The reason why no
correlation was found between the HOMA index and
IMT measurements in morbidly obese women and a
positive correlation was found when the groups were
combined might be the smaller number of patients in
the morbidly obese group.
Ciccone et al. could not demonstrate a correlation
between fasting insulin levels and CCA IMT in obese
(BMI ≥ 27 kg/m2) and nonobese (BMI < 27 kg/m2)
men and women (11). Likewise, De Pergola et al.
found no correlation between fasting insulin levels
and CCA IMT in normal weight (BMI < 25 kg/m2),
overweight (BMI 25–30 kg/m2), and obese (BMI >
30 kg/m2) premenopausal women (12). However,
they found a positive correlation between insulin
resistance measured by insulin tolerance test and
CCA IMT. They commented that this relationship
was independent of other cardiovascular risk
factors and insulin resistance per se accelerated the
atherosclerotic process. High insulin level is generally
regarded as a predictor of insulin resistance. However,
fasting insulin level is an indirect and insensitive
measure of insulin resistance. Therefore, according
to the authors of the study, the discrepancy between
the relationship of fasting insulin levels and IMT
and insulin resistance and IMT is not surprising. In
this study, we found that both fasting insulin levels
and the HOMA index were positively correlated
with ICA IMT in the combined group. Shinozaki
et al. and Suzuki et al. also demonstrated a positive
correlation between insulin resistance and IMT in
men and women with BMI < 25 kg/m2 (13,14). In the
study by Shinozaki et al., patients with vasospastic
angina pectoris were included (13). In the study by
Suzuki et al., patients with essential hypertension
were included (14). In our study, patients with other
comorbidities that could affect the results were
excluded. The correlation with CCA IMT was also
shown in an obese children population (15).
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Not all studies show a correlation between insulin
resistance and carotid artery atherosclerosis. Bonora
et al. compared nondiabetic subjects with a mean BMI
of 24.8 kg/m2 with diabetic patients with a mean BMI
of 29.4 kg/m2 (3). The patient groups were not in the
obesity range. They only found a positive correlation
between insulin resistance and IMT in diabetic
patients. In a population-based study in nondiabetic
subjects, Hedblad et al. found a positive correlation
between HOMA index and IMT; however, this
correlation disappeared after adjustments for other
confounders were made (16).
In this study, there was a statistically significant
difference in carotid artery IMT measurements
among the 3 groups, being greatest in the morbidly
obese group. In the combined morbidly obese and
obese group, BMI was positively correlated with CCA
and ICA IMT. This result shows that excess body fat
is related to arterial wall thickness and atherosclerosis
is accelerated in obesity. Carotid artery IMT is used
as a marker for end organ damage because increased
IMT is an early change in the atherosclerotic process.
In a study by Salonen and Salonen, CCA IMT was
positively correlated with the risk of coronary
heart disease (17). The results of our study are in
concordance with other studies (11,18–20).
Measurement of carotid artery IMT by B-mode
ultrasonography is recommended for risk assessment
by the American Heart Association (21). In most
of the studies, different regions were used, but the
results may differ according to the region selected.
Focal atherosclerotic plaques are found to be more
prevalent in the ICA than the CCA. Likewise, ICA
IMT is much more correlated with coronary artery
disease and myocardial risk factors than CCA IMT
(22). In this study, bilateral ICA, CCA, and BCA
measurements were done and the mean values of
the right and left were calculated. ICA IMT, which
is more valuable than CCA IMT as discussed above,
was found to be better correlated with parameters
such as fasting insulin and HOMA indexes.
When lipid profiles were compared, only
triglyceride and HDL cholesterol differed significantly
among the 3 groups. When the combined group of
obese and morbidly obese women was compared to
the control group, all of the lipid parameters differed
significantly. Similar results were shown in other
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studies (23–26). When morbidly obese and obese
groups were compared separately, none of the lipid
parameters differed significantly. These results were
similar to the results of another study in which the
metabolic profile of morbidly obese (BMI ≥ 40 mg/
m2) women was not deteriorated as expected when
compared to moderately obese (BMI 30–40 kg/m2)
women (27). Therefore, it can be assumed that the
degree of obesity may not be directly correlated with
the deterioration of the lipid profile. In the morbidly
obese group, HDL cholesterol, but no other lipid
parameters, was negatively correlated with fasting
insulin and the HOMA index. Hyperinsulinemia is
shown to be related to increases in triglycerides and

decreases in HDL cholesterol rather than any changes
in total or LDL cholesterol (28). Defects in insulin
signaling may result in proatherogenic lipid profiles
in peripheral tissues such as adipose tissue (29).
In conclusion, this study shows the relation
between BMI, hyperinsulinemia, insulin resistance,
and carotid artery IMT. The results confirm that
obesity is related with carotid artery IMT and
accelerates atherosclerosis. Although there are
studies showing this relationship, the morbidly obese
group was analyzed separately in this study. Studies
with more patients will further clarify the results of
this study.
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